n(6)-carboxymethyllysine has been researched along with mocetinostat in 4 studies
| Studies (n(6)-carboxymethyllysine) | Trials (n(6)-carboxymethyllysine) | Recent Studies (post-2010) (n(6)-carboxymethyllysine) | Studies (mocetinostat) | Trials (mocetinostat) | Recent Studies (post-2010) (mocetinostat) |
|---|---|---|---|---|---|
| 803 | 44 | 365 | 21,735 | 390 | 8,606 |
| Protein | Taxonomy | n(6)-carboxymethyllysine (IC50) | mocetinostat (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 0.7851 | |
| Nuclear receptor corepressor 1 | Homo sapiens (human) | 0.022 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.57 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.102 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.102 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.5717 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.3433 | |
| Histone deacetylase 7 | Homo sapiens (human) | 0.6725 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.3537 | |
| Histone deacetylase 11 | Homo sapiens (human) | 0.6386 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.6725 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.5717 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.6725 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, MM; Crowley, JR; Heinecke, JW; Requena, JR; Thorpe, SR | 1 |
| Monnier, VM; Obrenovich, M; Saxena, AK; Saxena, P; Weiss, MF; Wu, X | 1 |
| Baidoshvili, A; Bleeker, W; Ciurana, C; Eijsman, L; Hack, CE; Krijnen, PA; Kupreishvili, K; Meijer, CJ; Niessen, HW; Nijmeijer, R; Schalkwijk, CG; Stooker, W; van Hinsbergh, VW; Visser, CA; Visser, FC | 1 |
| Aikawa, H; Eto, A; Hanada, H; Hiraoka, F; Iko, M; Inoue, R; Kazekawa, K; Kiyomi, F; Mitsutake, T; Nagai, R; Nii, K; Sakamoto, K; Sakata, N; Shirakawa, JI; Tsutsumi, M | 1 |
4 other study(ies) available for n(6)-carboxymethyllysine and mocetinostat
| Article | Year |
|---|---|
The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.
Topics: Aldehydes; Catalase; Cations; Cells, Cultured; Chelating Agents; Glycosylation; Humans; Hydrogen Peroxide; Hypochlorous Acid; Inflammation; Lysine; Maillard Reaction; Neutrophils; Oxidation-Reduction; Peroxidase; Protein Processing, Post-Translational; Ribonuclease, Pancreatic; Serine; Sodium Azide | 1999 |
Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: relevance to diseases of glycoxidative stress.
Topics: Animals; Ascorbic Acid; Binding Sites; Biopolymers; Catalysis; Cations, Divalent; Collagen; Copper; Diabetes Mellitus, Experimental; Free Radicals; Glycation End Products, Advanced; Humans; Hydrogen Peroxide; Kidney Failure, Chronic; Lysine; Methylation; Oxidation-Reduction; Oxidative Stress; Peroxidase; Rats; Rats, Sprague-Dawley; Serine | 1999 |
N(epsilon)-(carboxymethyl)lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction?
Topics: Aged; Animals; Coronary Vessels; E-Selectin; Endothelial Cells; Female; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocarditis; Oxidative Stress; Peroxidase; Prognosis; Rats; Risk Factors; Time Factors | 2006 |
N
Topics: Aged; Aged, 80 and over; Biomarkers; Carotid Arteries; Carotid Stenosis; Chi-Square Distribution; Chromatography, Liquid; Diffusion Magnetic Resonance Imaging; Embolic Protection Devices; Endovascular Procedures; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Lysine; Magnetic Resonance Angiography; Male; Molecular Imaging; Multivariate Analysis; Peroxidase; Plaque, Atherosclerotic; Predictive Value of Tests; Registries; Risk Assessment; Risk Factors; Stents; Tandem Mass Spectrometry; Treatment Outcome | 2017 |